CC241122P18000
- 0.01
- 0.000.00%
The Chemours Newsroom
Chemours (NYSE:CC) Use Of Debt Could Be Considered Risky
(CC) - Analyzing Chemours's Short Interest
The Chemours To Go Ex-Dividend On November 15th, 2024 With 0.25 USD Dividend Per Share
Express News | Chemours Co - Proceeds to Redeem Euro-Denominated 4.000% Senior Notes Due 2026
Express News | The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033
Why Chemours' (NYSE:CC) Earnings Are Better Than They Seem
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 4% Dividend Yields
Chemours' Earnings and Revenues Surpass Estimates in Q3
RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $25
Chemours Is Maintained at Equal-Weight by Morgan Stanley
Chemours Analyst Ratings
Express News | Chemours Co : Morgan Stanley Cuts Target Price to $25.00 From $30.00
Should You Investigate The Chemours Company (NYSE:CC) At US$20.58?
Barclays Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $23
Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating
Chemours Reports Q3 2024 Results and Strategic Update
Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30
Update: Chemours Shares Jump After Q3 Results Come Ahead of Estimates
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
The Chemours Company (CC) Q3 2024 Earnings Call Transcript Summary